ARDX is trading 5.1% down at $4.96 as technical selling and profit-taking drive a sharp multi-day slide from last week's highs above $6.
- The move appears idiosyncratic, with the stock underperforming broader indices amid lingering pressure from recent biotech sector volatility.
- No fresh, company-specific headlines have been released, suggesting the decline is fueled by elevated trading volumes following prior gains.